[INARI] YoY Annualized Quarter Result on 31-Mar-2019 [#3]

Stock
[INARI] INARI AMERTRON BERHAD
Announcement Date
23-May-2019
Admission Sponsor
-
Sponsor
-
Financial Year
30-Jun-2019
Quarter
31-Mar-2019 [#3]
Profit Trend
QoQ- -11.24%
YoY- -20.16%
Quarter Report
Latest QR
Upcoming QR
INARI's Result
INARI's Financial Summary
View:
Show?
Annualized Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 1,615,629 1,423,178 1,099,480 1,176,253 1,433,173 1,107,548 1,047,880 7.47%
PBT 450,832 345,138 184,397 222,592 285,409 224,806 149,073 20.24%
Tax -43,861 -22,416 -24,000 -17,232 -27,718 -7,916 -4,970 43.73%
NP 406,970 322,722 160,397 205,360 257,690 216,890 144,102 18.88%
-
NP to SH 406,268 322,817 160,369 204,572 256,217 216,305 144,448 18.79%
-
Tax Rate 9.73% 6.49% 13.02% 7.74% 9.71% 3.52% 3.33% -
Total Cost 1,208,658 1,100,456 939,082 970,893 1,175,482 890,657 903,777 4.96%
-
Net Worth 2,474,164 1,385,890 1,190,979 1,107,854 1,026,872 824,131 634,339 25.45%
Dividend
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Div 385,256 375,939 142,477 174,582 178,756 180,900 77,138 30.72%
Div Payout % 94.83% 116.46% 88.84% 85.34% 69.77% 83.63% 53.40% -
Equity
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Net Worth 2,474,164 1,385,890 1,190,979 1,107,854 1,026,872 824,131 634,339 25.45%
NOSH 3,705,170 3,338,921 3,239,284 3,171,129 2,076,018 1,938,219 933,126 25.82%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 25.19% 22.68% 14.59% 17.46% 17.98% 19.58% 13.75% -
ROE 16.42% 23.29% 13.47% 18.47% 24.95% 26.25% 22.77% -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 43.61 42.90 33.95 36.83 68.42 57.14 112.30 -14.57%
EPS 11.11 9.81 5.03 6.47 12.60 11.16 15.48 -5.37%
DPS 10.40 11.33 4.40 5.47 8.53 9.33 8.27 3.89%
NAPS 0.6679 0.4178 0.3678 0.3469 0.4902 0.4252 0.6798 -0.29%
Adjusted Per Share Value based on latest NOSH - 3,171,129
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
RPS 42.65 37.57 29.02 31.05 37.83 29.24 27.66 7.48%
EPS 10.72 8.52 4.23 5.40 6.76 5.71 3.81 18.80%
DPS 10.17 9.92 3.76 4.61 4.72 4.78 2.04 30.68%
NAPS 0.6531 0.3658 0.3144 0.2924 0.2711 0.2175 0.1674 25.45%
Price Multiplier on Financial Quarter End Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 31/03/22 31/03/21 31/03/20 29/03/19 30/03/18 31/03/17 31/03/16 -
Price 3.07 3.28 1.24 1.57 2.75 2.04 3.22 -
P/RPS 7.04 7.64 3.65 4.26 4.02 3.57 2.87 16.12%
P/EPS 27.99 33.70 25.04 24.51 22.48 18.28 20.80 5.07%
EY 3.57 2.97 3.99 4.08 4.45 5.47 4.81 -4.84%
DY 3.39 3.46 3.55 3.48 3.10 4.58 2.57 4.72%
P/NAPS 4.60 7.85 3.37 4.53 5.61 4.80 4.74 -0.49%
Price Multiplier on Announcement Date
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Date 13/05/22 21/05/21 21/05/20 23/05/19 22/05/18 16/05/17 18/05/16 -
Price 2.56 3.00 1.44 1.32 2.16 2.18 2.72 -
P/RPS 5.87 6.99 4.24 3.58 3.16 3.82 2.42 15.90%
P/EPS 23.34 30.83 29.08 20.61 17.66 19.53 17.57 4.84%
EY 4.28 3.24 3.44 4.85 5.66 5.12 5.69 -4.63%
DY 4.06 3.78 3.06 4.14 3.95 4.28 3.04 4.93%
P/NAPS 3.83 7.18 3.92 3.81 4.41 5.13 4.00 -0.72%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment